Alliance Pharma PLC Interim Dividend Timetable (1244H)
November 26 2015 - 11:35AM
UK Regulatory
TIDMAPH
RNS Number : 1244H
Alliance Pharma PLC
26 November 2015
For immediate release 26 November 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Interim Dividend Timetable - Revised Record Date
Alliance Pharma plc (AIM: APH), the specialty pharmaceutical
company, announces that in light of the announcement earlier today
regarding the proposed acquisition of the Healthcare Products
Business from Sinclair IS Pharma plc (the "Acquisition"), and the
associated vendor placing, the Company is deferring the record date
for its Interim Dividend to 29 December 2015 (from 18 December
2015). The payment date remains 14 January 2016, as announced in
the Company's interim results on 9 September 2015.
This change accommodates any unexpected delay in completion of
the Acquisition up to the long stop date of 28 December 2015 and
ensures that placees receive the interim dividend to which they are
entitled.
For further information:
Alliance Pharma
plc
John Dawson, Chief + 44 (0) 1249
Executive 466966
Numis Securities
Limited
Nominated Adviser: Michael Meade + 44 (0) 20
/ Freddie Barnfield 7260 1000
Corporate Broking: David
Poutney / James Black
Buchanan
Mark Court / Sophie Cowles + 44 (0) 20
/ Jane Glover 7466 5000
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCQQLFLEFFXFBB
(END) Dow Jones Newswires
November 26, 2015 11:35 ET (16:35 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024